"Siasun Robot & Automation, the leader in comprehensive intelligent in-house logistics, Kaiross (02729) opens its IPO: possessing three core products MSR, AMR, and CSR."
On March 16, the logistics robot leader K-One Technology (02729) officially started the IPO, and the subscription period will end on March 19.
On March 16, logistics company Siasun Robot & Automation's flagship Keles (02729) officially started its IPO, with the IPO period ending on March 19. The company plans to globally issue 36.798 million H-shares, with approximately 10% for public offering in Hong Kong and approximately 90% for international offering, with an additional 15% over-allotment option. The offering price will be HK$16.40-20.40 per share. It is expected that the H shares will start trading on the Stock Exchange on March 24, 2026 (Tuesday) with a minimum trading unit of 200 shares.
On March 8, Keles officially passed the listing hearing on the main board of the Hong Kong Stock Exchange, with GUOTAI JUNAN I, CITIC SEC as joint sponsors. As one of the few leading companies globally with comprehensive intelligent in-plant logistics Siasun Robot & Automation technology, the company is poised to take the crown of the "first stock of comprehensive intelligent in-plant logistics Siasun Robot & Automation" on the Hong Kong stock market and is expected to garner high market attention.
According to the prospectus, Keles is a provider of comprehensive intelligent in-plant logistics Siasun Robot & Automation, offering a variety of Siasun Robot & Automation products primarily in three core product lines: Multi-directional shuttle Siasun Robot & Automation (MSR), Autonomous Mobile Siasun Robot & Automation (AMR), and Conveyor Sorting Siasun Robot & Automation (CSR). The company's Siasun Robot & Automation product portfolio features core functions of storage, sorting, and transportation, covering the entire in-plant logistics business scope. Keles is one of the mature companies in the intelligent in-plant logistics Siasun Robot & Automation industry, possessing extensive Siasun Robot & Automation technological capabilities and a diversified self-developed Siasun Robot & Automation product portfolio, covering commonly used core in-plant logistics functions with high payloads.
In terms of the industry, driven by rising operating costs, increasing complexity, and the constant demand for efficiency in the traditional logistics industry, according to Frost Sullivan data, the global intelligent in-plant logistics market is estimated to reach RMB 522.8 billion by 2025 and RMB 991.9 billion by 2030, with a compound annual growth rate of 13.7%.
China is an important market in the intelligent in-plant logistics industry, with the market size increasing from RMB 96 billion in 2020 to RMB 175.9 billion in 2024, with a compound annual growth rate of 16.3%. It is estimated that the market size will reach RMB 413.7 billion by 2030, with a compound annual growth rate of 15.1% from 2025 to 2030. Keles has long been dedicated to innovation in intelligent in-plant logistics and is the first company in China to independently develop and commercialize four-directional bins MSR. Based on the 2024 revenue, Keles ranks among the top five comprehensive intelligent in-plant logistics Siasun Robot & Automation companies in China.
Through long-term accumulation of project design and deployment cases, Keles has developed an evaluation framework that is applicable to the entire industry, all facility types, and all business models. This framework extracts key parameters of the three core functions of in-plant logistics (storage, transportation, sorting) and aligns well with the product portfolio logic. The MSR, AMR, and CSR product lines each have unique characteristics in the three core functions and in the five dimensions of flexibility and scalability.
In terms of production, Keles has established a highly structured and standardized production process, combining strict quality control with efficient resource management to ensure optimal output capacity and high product quality. Production schedules and plans are formulated based on market demand, customer orders, inventory levels, and production facility utilization. As of the final feasible date, the company has two production bases in Jiaxing and Wuhu. The Jiaxing plant mainly produces MSR and AMR, while the Wuhu plant mainly produces CSR.
In terms of shareholders, according to the prospectus, major shareholders include Dr. Gu Chunguang, Zhongjin Fund, SF Technology, and China Merchant Bureau of Advanced Technology.
Additionally, according to the company's financial data, Keles had total revenue of RMB 551 million in 2023, RMB 721 million in 2024, and achieved revenue of RMB 552 million in the first three quarters of 2025.
Related Articles

SSY GROUP (02005): Bumetanide has been approved by the National Medical Products Administration and registered as an active pharmaceutical ingredient for use in marketed preparations.

KNOWLEDGE ATLAS (02513) releases a large model specifically designed for lobsters. Despite a 20% price increase, demand still exceeds supply.

Selling models is not as good as selling AI employees: KNOWLEDGE ATLAS (02513) launches lobster meal set priced at 99 yuan to seize the entrance of digital employees in enterprises.
SSY GROUP (02005): Bumetanide has been approved by the National Medical Products Administration and registered as an active pharmaceutical ingredient for use in marketed preparations.

KNOWLEDGE ATLAS (02513) releases a large model specifically designed for lobsters. Despite a 20% price increase, demand still exceeds supply.

Selling models is not as good as selling AI employees: KNOWLEDGE ATLAS (02513) launches lobster meal set priced at 99 yuan to seize the entrance of digital employees in enterprises.






